2021
DOI: 10.1016/j.neurobiolaging.2021.01.001
|View full text |Cite
|
Sign up to set email alerts
|

Bacille Calmette-Guérin attenuates vascular amyloid pathology and maximizes synaptic preservation in APP/PS1 mice following active amyloid-β immunotherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 75 publications
0
7
0
Order By: Relevance
“…It was consistent with the reported results that APP could mediate the production of Aβ and affect the density of brain perivascular macrophages in the vasculature of the hippocampus ( Karam et al, 2022 ). A previous study found that the recruited macrophages could enhance the vascular Aβ phagocytosis for immunotherapy in APP/PS1 mice ( Zuo et al, 2021 ). In addition, the deposition of vascular Aβ in the cerebral vasculature could cause breakdown of the vascular integrity and a decrease in the number of cerebrovascular endothelial cells and pericytes ( Sweeney et al, 2018 ).…”
Section: Discussionmentioning
confidence: 99%
“…It was consistent with the reported results that APP could mediate the production of Aβ and affect the density of brain perivascular macrophages in the vasculature of the hippocampus ( Karam et al, 2022 ). A previous study found that the recruited macrophages could enhance the vascular Aβ phagocytosis for immunotherapy in APP/PS1 mice ( Zuo et al, 2021 ). In addition, the deposition of vascular Aβ in the cerebral vasculature could cause breakdown of the vascular integrity and a decrease in the number of cerebrovascular endothelial cells and pericytes ( Sweeney et al, 2018 ).…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, animal studies in mice have shown that infections such as influenza have been shown to cause neuroinflammation resulting in long-term neurological sequelae, which can be prevented by vaccination. 49,50 This provides another potential link between vaccinations and reduced inflammation and neurodegeneration.…”
Section: Discussionmentioning
confidence: 99%
“…Vaccines have been shown to non-specifically activate Toll-like receptors leading to an increase in microglial/macrophage activity reducing neuroinflammation, and two studies with BCG vaccination in APP/PS1 mice have shown that BCG vaccination improves cognition and reduces neuroinflammation. 49 Vaccines may therefore reduce the risk of dementia through activation of regulatory T cells, 51 training the immune system, 24 increasing microglial/macrophage activity, 52 and reduction of chronic inflammation, as well as reducing incidence of infections associated with dementia. 34 This evidence provides a necessary connection between the related roles of inflammation and immune function in dementia and Alzheimer's risk.…”
Section: Discussionmentioning
confidence: 99%
“… 7–9 Our research group previously observed that BCG improves cognitive impairment in APP/PS1 mice and reduces the neuroinflammatory responses, suggesting the existence of an altered cytokine dynamic that possibly impacts the dendritic morphology in the hippocampus. 10 , 11 Hence, in this study, we analyzed the dendrites complexity of hippocampal pyramidal neurons following immunization of APP/PS1 mice with BCG. It is worth noting that, APP/PS1 mice showed cognitive decline from the age of 6 months, however, hippocampal mossy fiber synapses display morphological and functional presynaptic deficits in middle-aged mice (3 to 6 months).…”
Section: Discussionmentioning
confidence: 99%
“…Alzheimer’s disease (AD) is a neurodegenerative disease, and immunotherapy has been identified as an important direction for clinical treatment. The use of BCG in APP/PS1 mice has been reported; 10 , 11 however, the specific mechanism for the neuroprotective effect of BCG on synaptic damage remains unclear.…”
Section: Introductionmentioning
confidence: 99%